Latest Acute myeloid leukemia Stories
SAN DIEGO, Sept. 9, 2014 /PRNewswire/ -- MEI Pharma, Inc.
SAN DIEGO and TORONTO, Sept.
AMSTERDAM, September 3, 2014 /PRNewswire/ -- ~ Clinical and Business Development expert re-joins the Company ~ Kiadis Pharma B.V.
SAN DIEGO, Aug.
Immunosuppressive drugs called thiopurines have been found to increase the risk of myeloid disorders, such as acute myeloid leukemia and myelodysplastic syndrome, a rare bone marrow disorder, seven-fold among inflammatory bowel disease (IBD) patients.
Leukotuximab is a novel, first-in-class Leukemia-specific mAb targeting JL-1 SHENYANG, China, Aug.
Live Webcasts from New York on August 13th and Boston on August 14th SAN DIEGO, Aug. 6, 2014 /PRNewswire/ -- MEI Pharma, Inc.
TORONTO, July 28, 2014 /PRNewswire/ - Lorus Therapeutics Inc.
- Findings from Phase II clinical study of investigational compound volasertib include response rate and new overall survival data. RIDGEFIELD, Conn., July 8, 2014 /PRNewswire/ --
Approval to Begin Clinical Laboratory Operations in Support of PraediCare-Dx(TM) Portfolio CAMBRIDGE, Mass., June 16, 2014 /PRNewswire/ -- EUTROPICS Inc., a privately held company